Immunotherapy for the treatment of Herpes Simplex Virus eye infections is disclosed. The invention involves a local therapeutic or prophylactic vaccine for the eye, comprising one or more recombinant HSV-1 glycoproteins or proteins, specifically gB and gD, in combination with at least...http://www.google.fr/patents/US5679348?utm_source=gb-gplus-shareBrevet US5679348 - Immunotherapy for recurrent HSV infections
